Article Text

Download PDFPDF
Distribution of HIV self-tests by men who have sex with men attending a French sexual health centre: results of the OTO study
  1. Daniel Gosset1,2,
  2. Marine Plathey2,
  3. France Lert3,
  4. Stéphane Lasry1,2,
  5. Thibaut Jedrzejewski2,
  6. Philippe Gazalet2,
  7. Thomas L'Yavanc2,4,
  8. Nadège Pierre2,
  9. Abdessamad Kachal2,
  10. Marc Frémondière2,
  11. Michel Ohayon1,2,
  12. Romain Palich2,5
  1. 1Department of Infectious Disease, Hospital Tenon, Paris, France
  2. 2"Le 190" Sexual Health Center, Paris, France
  3. 3Vers Paris Sans Sida, Paris, France
  4. 4Hôpital Jean Jaurès, Paris, France
  5. 5Sorbonne University, Paris, France
  1. Correspondence to Dr Daniel Gosset, Hospital Tenon, Paris, France; dgosset{at}le190.fr

Abstract

Objectives HIV self-tests (HSTs) have been deployed to reduce the burden of undiagnosed HIV infections in subpopulations undertested. We assumed that patients attending sexual health centres could themselves distribute HSTs in their close network. This study aimed to assess the proportion and the characteristics of the participants who distributed HSTs, as well as the characteristics of people who received HSTs.

Methods Three HSTs were given to patients attending “Le 190” Sexual Health Center, Paris, France, having consented for the study, between July 2018 and August 2020. Participants had to distribute HSTs within 6 months, preferably to individuals in their close circle who have not been tested for a long time. Then they had to complete a self-questionnaire, exploring HIV status, sexual practices, number of distributed HSTs, profile of persons who received HSTs, and if known, result of used HSTs. Univariable logistic regression was used to determine factors associated with HST distribution.

Results Overall, 682/1062 (64%) patients accepted to be included in the study, and 283/682 (42%) completed the questionnaire. 97% were men who have sex with men (MSMs), including 86 (30%) HIV-positive individuals and 119 (42%) HIV Pre-Exposure Prophylaxis (PrEP) users. The proportion of participants having distributed 0, 1, 2 or 3 HSTs was 31%, 15%, 27% and 27%, respectively. Participants having distributed at least one HST (n=195, 69%) were more likely to have previously used HSTs themselves (OR=3.90, 95% CI=1.84 to 8.29, p<0.001). On the 901 HSTs in possession of participants who answered the questionnaire, 455 (50%) were distributed. 79% of recipients were MSMs, and 42% of whom had not been tested for more than 1 year. The result was known for 220 HSTs, including 5 positive (2.3%).

Conclusion MSMs attending sexual health centres could be good disseminators of HSTs, targeting a population with high level of undiagnosed HIV infections, especially if they have already experimented it.

  • HIV
  • Point-of-Care Testing
  • Homosexuality, Male

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Anna Maria Geretti

  • Presented at This work has been presented as an oral communication at the 18th European AIDS Conference, London, UK, on the 28 October 2021 (Abstract O3/4).

  • Contributors DG, MP, FL, MF and MO conceived and planned the experiments. DG, MP, FL, SL, TJ, PG, TL, NP, AK, MF, MO and RP carried out the experiments. DG, MP, MF, MO and RP contributed to the interpretation of the results. RP and DG took the lead in writing the manuscript. All authors provided critical feedback and helped shape the research, analysis and manuscript.

  • Funding This study was supported by Vers Paris Sans Sida, COREVIH Ile-de-France Centre and AIDES.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.